- Home
- VCEL vs GENI Comparison
VCEL vs GENI Comparison
Compare VCEL & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | GENI |
|---|---|---|
| Founded | 1989 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VCEL | GENI |
|---|---|---|
| Price | $32.58 | $5.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 16 |
| Target Price | ★ $58.50 | $13.19 |
| AVG Volume (30 Days) | 468.7K | ★ 5.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.09 | $29.73 |
| Revenue Next Year | $17.96 | $28.38 |
| P/E Ratio | $101.67 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $29.24 | $4.96 |
| 52 Week High | $48.75 | $13.73 |
Technical Indicators
Market Signals| Indicator | VCEL | GENI |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 33.48 |
| Support Level | $31.34 | N/A |
| Resistance Level | $38.48 | $6.75 |
| Average True Range (ATR) | 1.42 | 0.42 |
| MACD | -0.31 | 0.06 |
| Stochastic Oscillator | 20.52 | 22.09 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.